Cobimetinib Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. COBIMETINIB (koe bi me ti nib) is a medicine that targets proteins in cancer cells and stops the cancer cells from growing. It is used to treat certain types of melanoma, a skin cancer. This medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions. Cobimetinib Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Cobimetinib Nitroso CAS NO:NA chemically represented as (S)-(3,4-Difluoro-2-((2-fluoro-4-iodophenyl)amino)phenyl)(3-hydroxy-3-(1-nitrosopiperidin-2-yl)azetidin-1-yl)methanone. Synchemia is the leading manufacturing and exporter of Cobimetinib Nitroso . We supply Cobimetinib Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142019 |
| CAS No | NA |
| Mol.F. | C19H18N2O |
| Mol.Wt. | 290.37 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142020 |
| CAS No | NA |
| Mol.F. | C21H22N2O3 |
| Mol.Wt. | 350.42 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142021 |
| CAS No | NA |
| Mol.F. | C26H34N2O9 |
| Mol.Wt. | 518.56 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142022 |
| CAS No | NA |
| Mol.F. | C17H25IN2O5 |
| Mol.Wt. | 464.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142023 |
| CAS No | NA |
| Mol.F. | C17H22N2O3 |
| Mol.Wt. | 302.37 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142024 |
| CAS No | NA |
| Mol.F. | C17H26N2O3 |
| Mol.Wt. | 306.41 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142025 |
| CAS No | NA |
| Mol.F. | C10H12N6O5 |
| Mol.Wt. | 296.24 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142026 |
| CAS No | NA |
| Mol.F. | C19H18FN7O6 |
| Mol.Wt. | 459.39 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142027 |
| CAS No | NA |
| Mol.F. | C22H28N2O4 |
| Mol.Wt. | 384.14 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142028 |
| CAS No | NA |
| Mol.F. | C10H12N2O |
| Mol.Wt. | 176.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142029 |
| CAS No | NA |
| Mol.F. | C12H12N2O |
| Mol.Wt. | 200.1 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142030 |
| CAS No | NA |
| Mol.F. | C31H48N2O12 |
| Mol.Wt. | 640.7 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142031 |
| CAS No | NA |
| Mol.F. | C20H22N2O5 |
| Mol.Wt. | 370.41 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142032 |
| CAS No | NA |
| Mol.F. | C16H16N2O6 |
| Mol.Wt. | 332.31 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142033 |
| CAS No | NA |
| Mol.F. | C21H20N2O8 |
| Mol.Wt. | 428.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142034 |
| CAS No | NA |
| Mol.F. | C17H10N2O8 |
| Mol.Wt. | 370.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |